There is an urgent need for reliable high-throughput serological assays for the management
of the ongoing COVID-19 pandemic. Preferably, the performance of serological tests for a …

Background Understanding the false negative rates of SARS-CoV-2 RT-PCR testing is
pivotal for the management of the COVID-19 pandemic and it has implications for patient …

Introduction The COVID-19 pandemic has led to high demand of diagnostic tools. Rapid
antigen detection tests have been developed and many have received regulatory acceptance …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused
millions of infections and fatalities globally since its emergence in late 2019. The virus was …

The emergence of SARS-CoV-2 Omicron variant (B. 1.1. 529) as of November 2021 changed
the epidemiology of COVID-19 with rapid upsurge of cases globally [1, 2]. In Finland, the …

Background In immunocompromised patients, persistent SARS-CoV-2 viral shedding and
relapsing COVID-19 pneumonia have been described. Currently, little is known about the …

Background Rapid sample-to-answer tests for detection of SARS-CoV-2 are emerging and
data on their relative performance is urgently needed. Objectives We evaluated the analytical …

Despite the widespread use of the current Bacillus Calmette–Guérin (BCG) vaccine, tuberculosis
is still a major cause of morbidity and mortality worldwide. Vaccination with BCG does …

Background Selective reporting is a promising tool for antimicrobial stewardship, but in wound
cultures, its effects on the use of antimicrobials are unknown. Our HUS Diagnostic Center …

Tuberculosis remains a major global health challenge despite extensive vaccination schemes
with the current live vaccine, Bacillus Calmette–Guérin. Tuberculosis vaccine research …